Fast Field-Cycling (FFC) MRI allows switching of the magnetic field during an imaging scan. FFC-MRI takes advantage of the T 1 dispersion properties of contrast agents to improve contrast, thus enabling more sensitive detection of the agent. A new contrast agent designed specifically for use with FFC was imaged using both a homebuilt FFC-MRI system and a 3 T Philips clinical MRI scanner. T 1 dispersion curves were obtained using a commercial relaxometer which showed large changes in relaxation rate between fields. A model of magnetization behaviour was used to predict optimum evolution times for maximum T 1 contrast between samples at each field. Images were processed and analysed to create maps of R 1 values using a set of images at each field. The R 1 maps produced at two different fields were then subtracted from each other in order to create a map of ∆R 1 in which pixel values depend on the change in R 1 of the sample between the two fields. The dispersion properties of the agent resulted in higher contrast in a ∆R 1 image compared with a standard T 1 -weighted image.
Introduction
In contemporary MRI, high magnetic fields (usually above 1.5 T) are used to generate high signal-tonoise ratio (SNR) (Redpath 1998) . However, the T 1 values of different tissue types often tend to converge at higher field strengths (above 1.5 T), resulting in inherently lower T 1 contrast (Rinck et al 1988) . While contrast agents can be used to improve the contrast between normal and pathological tissue, the relaxivity of the contrast agent is also dependent on magnetic field strength and tends to be lower at higher field strengths (Rinck et al 1988 , Carlson et al 1992 , Young et al 1981 , Bloembergen 1957 , Lauffer 1987 .
Clinical MRI scanners maintain a constant magnetic field B 0 , so that image contrast is inevitably restricted to that which results from differences in tissue NMR parameters (especially T 1 ) at the scanner's fixed field. On the other hand, Fast Field-Cycling MRI (FFC-MRI) allows the field to be switched between two or more values in a time less than the T 1 of the sample, always returning to the same magnetic field for signal detection (Carlson et al 1992 , Lurie et al 1998 , Lurie et al 2010 . Thus images can be produced at the magnetic field strength that optimizes contrast enhancement from contrast agents (Rinck et al 1988 , Carlson et al 1992 . This is done by analysing the dispersion curves of contrast agents and determining the field at which relaxivity (r 1 ) is highest. Furthermore, FFC-MRI allows access to a new type of contrast known as ∆R 1 contrast, in which signal intensity is based on the change in R 1 of a sample between different magnetic fields (Alford et al 2009) .
This work examines the potential of a new contrast agent, designed for molecular imaging applications using FFC-MRI. Molecular imaging investigations usually require probes that can be detected at concentrations in the nano-or even pico-molar range. The agent used here takes the form of a liposome encapsulating Mn [II] ions in its inner aqueous cavity. Liposomes containing a large amount of paramagnetic Mn [II] ions are expected to display the high relaxation enhancement necessary to tackle the sensitivity issues present in MR molecular imaging assays (Aime et al 2009) . The advantage of this contrast agent is the large change in its r 1 value from a high value at low fields (below 5 mT) to low r 1 at higher fields (above 60 mT), resulting in a large signal value in a ∆R 1 image. A comparison is made between ∆R 1 mapping using FFC-MRI and other imaging methods, including T 1 -weighted imaging and T 1 mapping at 3 mT, 59 mT and at a standard clinical field of 3 T. Contrast is seen to improve using ∆R 1 mapping. Moreover it is expected that such a system may show both good specificity and in vivo tolerability, as liposomes are commonly used as drug delivery agents to target diseased tissue and living organisms should be able to control the small excess of essential Mn [II] ions. Dara Ó Hógáin et al -Use of contrast agents with fast field-cycling magnetic resonance imaging Physics in Medicine and Biology 56, 105-115 (2011) 3 In order to demonstrate proof of purpose of this novel technique, it was considered sufficient to carry out experiments in vitro. The results show how contrast agent conspicuity can be improved using FFC-MRI.
Future studies are planned which will show in vivo validation of this new technique at carefully selected magnetic fields.
Magnetization Behaviour during field cycling
The contrast in a T 1 -weighted inversion-recovery image is largely dependent on the inversion time (TI) used. To optimize the contrast between two samples it is important to understand how the magnetization behaves with inversion time during a pulse. For a fixed-field inversion-recovery pulse sequence the magnetization behaviour can be described by the equation below.
( )
Where M(TI) is the magnetization at a time (TI) after the inversion pulse, M 0 is the equilibrium magnetization at the readout field, and T 1 is the longitudinal relaxation time constant of the sample. The optimum inversion time for maximum contrast between two samples with T 1 values T 1a and T 1b can be determined using the equation below (Ahrens et al 1998) . (2) However magnetization behaves differently during field-cycling, as the T 1 value changes between one field and another, thus magnetization evolves at different rates at each field as shown in figure 1. The magnetization of the sample is allowed to evolve at the evolution field for a time period (t evol ). The system then ramps back up to the acquisition field followed by a delay time (t d ) in order for the magnet to stabilize before a 90° pulse is applied. This is then followed by a gradient echo imaging sequence. The magnetization evolves continuously during the ramp time t ramp , the evolution time t evol and the delay time 
where M 0 D is the equilibrium magnetization at the readout field. M b is described by
In this case M 0 E is the equilibrium magnetization at the evolution field obtained using the ratio, B 0
Substituting Ma and Mb into Mfinal gives a full description of the magnetization behaviour during an FFC inversion recovery pulse sequence.
This equation was used to predict magnetization behaviour for a number of different samples with a range of T 1 time constants at different fields. To validate the equation a comparison was made with experimental data. Using this equation it was possible to select the evolution times which would give maximum contrast between any two samples using T 1 -weighted imaging techniques at different field strengths.
Methods

Sample Preparation
All the phospholipids used in the liposome preparation were purchased from Avanti Polar; MnCl 2 was purchased from Sigma Aldrich. Mn(II)-loaded liposomes were prepared by using a mixture of phospholipids (POPC = 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine, 95% and DSPE-PEG 2000 = Dara Ó Hógáin et al -Use of contrast agents with fast field-cycling magnetic resonance imaging Physics in Medicine and Biology 56, 105-115 (2011) 6 1,2-distearoyl-sn-glycero-3-phospoethanolamine-N-[metoxy(polyethylene glycol)-2000), 5%). The thin lipidic method was followed (Lasch et al 2003) . Briefly, the lipids (about 30 mg/ml) were dissolved in chloroform and the organic solution was slowly evaporated for removing the solvent until a thin film was formed. The film was then hydrated at 55 °C with a 5 mM aqueous solution of MnCl 2 , whose osmolarity was corrected to 300 mOSm with NaCl. The resulting suspension of multilamellar vesicles (MLV) was extruded (Lipex extruder, Northern Lipids Inc., Canada) through progressively smaller pore sizes (polycarbonate filters with pore diameters of 400, 200 and 100 nm, respectively). The final suspension of liposomes was purified from the not encapsulated metal ions by exhaustive dialysis against a HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)/NaCl buffer (pH 7.4, 300 mOsm). The liposomes were characterized by dynamic light scattering (Zetasizer NanoZS, Malvern, UK) in order to assess the mean hydrodynamic size and the polydispersity of the system. The liposomes used in this work showed an average diameter of 111 nm; the polydispersity index (PDI) was smaller than 0. 
Dispersion Curve Measurement
The samples were placed in NMR tubes and dispersion curves were measured. The dispersion curve shape of each sample depends on a combination of factors including; the concentration of the agent in the solution, the concentration of the entrapped paramagnetic molecule within the liposome, the type of paramagnetic species, the viscosity of the hydration solution, which gives rise to a peak at high fields, the membrane composition which affects the water exchange time, and the total size of the liposome, which relates to the reorientational correlation time.
Dispersion curves were obtained experimentally using a field-cycling pulse sequence on a commercial NMR relaxometer (Stelar S.r.l., Italy). Pre-polarization was typically at 187 mT, with detection at 169 105-115 (2011) 7 mT. At each value of the evolution field the sequence was repeated using N different values of the inversion time (TI), allowing T 1 to be calculated as a function of magnetic field (Ferrante and Sykora 2004) .
Imaging
An imaging phantom was constructed containing samples of Mn[II] contrast agent solutions arranged alongside a 0.23 mM sample of Prohance. The samples were contained in glass tubes with dimensions 1 cm diameter x 2 cm length. Samples were imaged on both a homebuilt whole-body FFC-MRI system (Lurie et al 1998) , and a 3 T Philips Achieva clinical MRI scanner. The FFC-MRI system employed two coaxial magnets. The primary permanent magnet provides a homogeneous fixed detection field of 58.7 mT (2.5 MHz proton frequency), while the secondary resistive electromagnet provided a variable offset field, capable of ramping from 0 to 58.7 mT in 40 ms (Lurie et al 1998) . During the ramp time the magnetic field changes linearly with time until the desired evolution field strength is reached. Following the ramp time there is a brief period of slight magnetic field instability (< 1 mT) caused by the time it takes the amplifier to switch off completely as well as by eddy currents induced in the coil. This instability occurs over a short time period and has negligible effect on the final bulk magnetization as described by equation 6. However a short delay has been implemented following field cycling ramps and before any RF pulse are applied, so that this instability does not affect the RF pulse efficiency. The total homogeneity of the evolution field was within 500 ppm. The stability of the evolution field is dependant on the current supply to the electromagnet, and has been found to vary by up to 1% which is stable enough not to affect the T 1 value of the sample.
3.3.1. T 1 weighted imaging. T 1 weighted images were acquired using the FFC-MRI scanner at 59 mT and 3 mT using a range of evolution times at each field, with evolution times carefully selected to show the maximum contrast between each Mn[II] sample and the Prohance sample. The inversion time following an inversion pulse is equivalent to the evolution time plus an additional 150 ms (which includes the time needed for both the ramp times (each 40 ms duration) plus the delay time (70 ms) before the 90° pulse.
The fields were selected to show maximum change in R 1 of the Mn[II] contrast agent. An FFC inversion recovery imaging pulse sequence was used as shown in figure 1 , but with the addition of imaging Dara Ó Hógáin et al -Use of contrast agents with fast field-cycling magnetic resonance imaging Physics in Medicine and Biology 56, 105-115 (2011) 8 gradients and a selective 90° pulse. The matrix size was 64 x 64, with number of excitations (NEX) = 1.
Image slice thickness was 0.8 cm, and the field of view (FOV) was 8 cm.
T 1 -weighted images were also acquired at 3 T using a Philips clinical MRI scanner, with a slice thickness of 0.8 cm and an FOV of 6 cm. The imaging phantom was placed in a knee coil and images were produced using a standard spin-echo inversion-recovery pulse sequence with a range of inversion times.
The samples' T 1 times were much longer at 3 T compared with 59 mT, thus a much wider range of inversion times was selected to produce an accurate R 1 map.
∆R 1 mapping.
A disadvantage of T 1 -weighted imaging in FFC-MRI is that the signal is dependent not only on the T 1 value of the sample but also on the equilibrium magnetization at the evolution field The experimental data was seen to match the predicted magnetization curve within experimental error, thus demonstrating that equation 6 could be used to predict magnetization behaviour during a fieldcycling inversion-recovery pulse sequence. The model could therefore be used to predict contrast as a function of evolution time in order to optimize T 1 -weighted contrast at any evolution field value.
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∆R 1 Mapping
A ∆R 1 map was produced by first creating maps of R 1 values at 59 mT and 3 mT. The R 1 maps were constructed using a program written in MATLAB (MathWorks, Natick, MA, USA) which overlaid a set of T 1 -weighted images acquired at a range of evolution times using an inversion-recovery pulse sequence.
The MATLAB program plotted signal intensity against evolution time to determine the R 1 value for each pixel in the set of images. R 1 maps were then subtracted to give a map of ∆R 1 . The measurement of the R 1 value was found to have a standard deviation of ~10% and ~15% at 59 mT and 3 mT respectively, while the standard deviation for the ∆R 1 map is ~25%. Uncertainty is dependent on a number of factors including the inherent signal-to-noise ratio, the variation of the sample magnetization with field, the number of evolution times used, and the number of signal averages used for each image (Ferrante and Sykora 2004) . 
Image Analysis
The contrast between Mn[II] liposome and Prohance samples was compared using contrast-optimized T 1 -weighted imaging at 3 T, 59 mT, 3 mT and ∆R 1 mapping. In order to compare contrast using these different imaging modalities the contrast between the Mn[II] samples and the Prohance sample was first defined as follows (Hendrick and Raff 1992) :
As shown in figure 7, this comparison reveals that contrast is significantly increased using ∆R 1 mapping compared with T 1 -weighted imaging. In particular, the contrast ratio between 1.0 mM Prohance and 0.045 mM Mn[II] samples (with T 1 values of 812 ms and 765 ms respectively) in the T 1 -weighted image obtained at 3 T is 36%. The contrast between these samples increases to 78% using ∆R 1 imaging which shows how the Mn[II] agent can be detected with significantly greater sensitivity using ∆R 1 mapping. It should be noted that the enhanced contrast is observed using data obtained at 3 mT and 59 mT, i.e. between one fiftieth and one thousandth of the field used in the high-field experiment. 
Discussion
The contrast between different concentrations of a new Mn [II] liposome-based contrast agent and a conventional agent (Prohance) was compared using different imaging methods. These imaging methods included T 1 -weighted imaging at 3 mT, 59 mT, and 3 T, and ∆R 1 mapping. Multiple images were used to produce a ∆R 1 map which allowed a quantitative analysis of the change in R 1 between different fields. This method suppressed the values from the Prohance sample, increased the sensitivity of detection of the applications. The present FFC-MRI system has shown consistency in its measurements and has provided proof-of-principle that ∆R 1 mapping can be used to improve the conspicuity of tailored contrast agents.
However the error inherent in ∆R 1 mapping remains a significant problem as it reduces the sensitivity of the technique to detect small changes in R 1 . In order to reduce error and improve sensitivity, more averages and more evolution times could be used in image acquisition. Unfortunately this would lead to longer imaging times. At present the time needed to produce multiple images at different field strengths is approximately 63 minutes, which is clearly too long for a clinical scan. However this time may be reduced using a faster T 1 mapping sequence such as an inversion-recovery Look-Locker echo-planar imaging sequence (Look and Locker 1970, Shin et al 2009) .
The main challenge to applying ∆R 1 mapping in vivo is to know at which fields to image in order to optimize contrast enhancement in a ∆R 1 map. This information can be obtained by acquiring dispersion curves in vivo of tissue with and without the contrast agent. To this end further work has been carried out in parallel to this study, to obtain localized dispersion curves in vivo. (Pine et al, 2009) . The relaxation curves of biological tissues have been studied extensively (Bottomley et al 1984 , Escanye et al 1982 , Fischer et al 1990 and tend to show relatively little change in R 1 at field strengths above 200 mT, whereas the Mn liposome samples exhibit large changes in R 1 within this field range (as shown in figure   2 ). To carry out in vivo experimental work a new FFC-MRI system with a field range between 0 and 0.5 16 tesla has been built in our laboratory and is in its final testing stages. This system will have improved field homogeneity, faster ramp times and a higher detection field, allowing more accurate and improved ∆R 1 mapping using FFC.
